November 21, 2016 Press release - Regulatory Targovax ASA: Registration of share capital increase following exercise of employee options
November 21, 2016 Press release - Regulatory Targovax ASA: Exercise of employee share options in Targovax ASA
November 18, 2016 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider
November 10, 2016 Press release - Regulatory Targovax granted European Patent for ONCOS platform lead product, ONCOS-102
November 8, 2016 Press release - Regulatory Targovax ASA: Invitation to third quarter 2016 results presentation Thursday 17 November
November 4, 2016 Press release - Regulatory Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
August 25, 2016 Press release - Regulatory Targovax ASA: Interim Report second quarter and first half year 2016
August 15, 2016 Press release - Regulatory Targovax ASA: Invitation to second quarter 2016 results presentation Thursday 25 August
July 1, 2016 Press release - Regulatory Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma
June 9, 2016 Press release - Regulatory Targovax receives regulatory approval in Spain to conduct a clinical trial with its oncolytic virus ONCOS-102
June 7, 2016 Press release - Regulatory Targovax ASA: Patient recruitment for TG01 immuno-oncology trial completed
June 2, 2016 Press release - Regulatory Targovax receives approval in Australia to conduct a clinical trial with TG02 – an immunotheraphy treatment targeting RAS mutations
May 9, 2016 Press release - Regulatory Targovax to present at BioEquity Europe and its first quarter 2016 results on May 11 – 12, 2016
April 14, 2016 Press release - Regulatory Targovax reports immune response with reduced number of TG01 vaccinations
March 14, 2016 Press release - Regulatory Targovax to present at forthcoming Life Science and Investor conferences
March 10, 2016 Press release - Regulatory Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer
February 25, 2016 Press release - Regulatory CORRECTION: Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation
February 25, 2016 Press release - Regulatory Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation
February 2, 2016 Press release - Regulatory Targovax submits a study of its adenovirus based immune therapy ONCOS-102 to the regulatory authorities in Spain
